Cefalexin / Cephalexin (Keflex)

Cefalexin, also commonly spelled cephalexin, is one of the most widely prescribed first-generation cephalosporin antibiotics in veterinary medicine. Originally developed for human use and marketed under brand names including Keflex, this antibiotic has become a cornerstone of canine antibacterial therapy due to its excellent safety profile, broad effectiveness against common pathogens, and convenient oral administration. Veterinarians frequently reach for cefalexin when treating bacterial infections in dogs because of decades of clinical experience demonstrating its reliability and predictable therapeutic outcomes.

The mechanism of action of cefalexin involves disruption of bacterial cell wall synthesis, a process essential for bacterial survival and reproduction. As a beta-lactam antibiotic, cefalexin binds to penicillin-binding proteins on the bacterial cell membrane, inhibiting the transpeptidase enzymes responsible for cross-linking peptidoglycan chains in the cell wall. Without a functional cell wall, bacteria cannot maintain their structural integrity, leading to osmotic instability and cell death. This bactericidal mechanism makes cefalexin particularly valuable for treating active infections where rapid elimination of pathogenic bacteria is the therapeutic goal.

Cefalexin is available in multiple oral formulations suitable for dogs of all sizes, including capsules, tablets, and oral suspension. The availability of various dosage strengths and formulation types allows veterinarians to prescribe the most appropriate option for each patient based on size, ease of administration, and owner preference. The oral suspension is particularly useful for small dogs and puppies where precise dosing with tablets may be challenging. Cefalexin is typically administered two to three times daily, with the specific frequency determined by the veterinarian based on the type and severity of infection being treated.

The safety profile of cefalexin in dogs is well-established through extensive clinical use over many years. Most dogs tolerate this antibiotic well when dosed appropriately according to veterinary instructions. As with all prescription medications, proper dosing based on accurate body weight is essential for both efficacy and safety. Veterinary supervision ensures that cefalexin is selected appropriately for the suspected bacterial pathogen and that the treatment course is adequate to fully resolve the infection while minimizing the risk of resistance development.

Cefalexin is primarily indicated for the treatment of bacterial skin infections in dogs, a category that includes superficial pyoderma, deep pyoderma, and skin fold infections. Canine pyoderma is one of the most common conditions encountered in veterinary dermatology, often caused by Staphylococcus pseudintermedius, an organism highly susceptible to first-generation cephalosporins. Dogs with pyoderma may present with pustules, papules, crusts, hair loss, and significant discomfort, and cefalexin provides effective treatment that leads to resolution of clinical signs when administered for an appropriate duration.

Urinary tract infections represent another major indication for cefalexin therapy in dogs. These infections, typically caused by bacteria ascending from the external environment into the bladder, result in clinical signs including increased urination frequency, straining to urinate, blood in urine, and inappropriate urination in house-trained dogs. Cefalexin achieves therapeutic concentrations in urine, making it effective against susceptible urinary pathogens including many strains of Escherichia coli, the most common cause of canine urinary tract infections. The veterinarian may recommend urine culture and sensitivity testing to confirm that the causative organism is susceptible to cefalexin.

Soft tissue infections and wound infections are additional important indications for cefalexin use in dogs. Dogs frequently sustain wounds through trauma, animal bites, surgical procedures, or accidents that can become contaminated with bacteria and develop into clinical infections. The excellent tissue penetration of cefalexin makes it effective for treating infections in skin, subcutaneous tissue, and muscle. Veterinarians may prescribe cefalexin prophylactically following certain surgical procedures or traumatic injuries to prevent infection development, or therapeutically once infection is established.

Respiratory tract infections in dogs may also be treated with cefalexin when caused by susceptible organisms. While many canine respiratory infections have viral origins or involve organisms not susceptible to cephalosporins, secondary bacterial infections can develop that respond to cefalexin therapy. Bone infections, or osteomyelitis, represent a more specialized indication for cefalexin, particularly when caused by Staphylococcus species. Bone infections typically require prolonged treatment courses of several weeks to months to achieve resolution.

The selection of cefalexin over other antibiotics considers multiple factors including the likely pathogen, site of infection, patient factors, and practical considerations. Cefalexin offers advantages including excellent oral bioavailability, a well-understood safety profile, availability in multiple formulations and strengths, and relative affordability compared to some newer antibiotics. When culture and sensitivity testing confirms susceptibility to first-generation cephalosporins, cefalexin can be prescribed with confidence that it will achieve therapeutic success in treating the identified infection.

The dosing of cefalexin in dogs is determined by the veterinarian based on the patient's body weight, the type of infection being treated, and individual patient factors that may affect drug handling. Weight-based dosing is essential because dogs range dramatically in size from toy breeds weighing just a few pounds to giant breeds exceeding 150 pounds. This enormous size variation means that a one-size-fits-all approach is impossible, and accurate weight measurement at the veterinary clinic forms the foundation for proper dosing. Owners should not estimate their dog's weight for dosing purposes.

Typical dosing protocols for cefalexin in dogs involve administration two to three times daily, depending on the clinical situation and the veterinarian's treatment approach. The total daily dose is divided into equal portions for each administration. Some infections may be adequately treated with twice-daily dosing, which improves owner convenience and compliance, while more serious or resistant infections may benefit from three-times-daily administration to maintain more consistent drug levels. The specific dosing regimen prescribed should be followed exactly as directed by the veterinarian.

Treatment duration with cefalexin varies significantly based on the type and severity of infection. Superficial skin infections may resolve with relatively shorter courses of therapy, typically extending for at least one week beyond the resolution of visible clinical signs. Deep pyoderma and more serious infections require extended treatment, often lasting several weeks or longer. Bone infections may require treatment courses of months to achieve complete resolution. Veterinarians typically schedule follow-up appointments to assess treatment response and determine when therapy can be safely discontinued.

Cefalexin can be administered with or without food, though giving the medication with a meal may help reduce gastrointestinal upset in some dogs. Capsules and tablets should be given whole unless the veterinarian provides specific instructions for dividing doses. The oral suspension should be shaken vigorously before each use to ensure uniform distribution of the medication throughout the liquid. For dogs that resist taking pills, hiding medication in a small amount of food, using pill pockets, or employing other techniques recommended by the veterinarian can facilitate administration.

Missed doses of cefalexin should be administered as soon as remembered, unless the next scheduled dose is approaching. In that case, the missed dose should be skipped and the regular schedule resumed without doubling up on doses. Giving a double dose can increase the risk of gastrointestinal side effects and provides no therapeutic advantage. Maintaining consistent intervals between doses helps sustain effective drug concentrations at the infection site. If multiple doses are missed or if the owner has questions about the dosing schedule, contacting the veterinary clinic for guidance is recommended.

Completing the full prescribed course of cefalexin is critically important for treatment success and prevention of antibiotic resistance. Even when dogs appear to have fully recovered before completing the medication, stopping early can allow surviving bacteria to repopulate and potentially develop resistance. Owners should never discontinue antibiotics independently based on perceived improvement without consulting the veterinarian. If side effects make continued treatment difficult, the veterinarian can provide alternatives rather than leaving the infection incompletely treated.

Cefalexin is generally well-tolerated by the majority of dogs when administered according to veterinary instructions. The first-generation cephalosporins have an excellent safety record in veterinary medicine, and serious adverse reactions are uncommon with appropriate dosing. However, as with any medication, side effects can occur, and pet owners should be informed about what to watch for during treatment. Awareness of potential reactions enables early recognition and appropriate intervention when needed.

The most commonly observed side effects of cefalexin in dogs involve the gastrointestinal system. Some dogs may experience decreased appetite, nausea, vomiting, or diarrhea during treatment with this antibiotic. These effects occur because cefalexin, like other antibiotics, can disrupt the normal bacterial flora of the intestinal tract, leading to digestive disturbances. Mild gastrointestinal upset is usually self-limiting and resolves as the dog continues treatment or shortly after completing the medication course. Administering cefalexin with food may help minimize stomach upset in dogs prone to this effect.

More persistent or severe gastrointestinal symptoms warrant veterinary attention. Bloody diarrhea, repeated vomiting, dehydration, or complete food refusal are signs that the dog's response to the medication requires professional evaluation. The veterinarian may recommend supportive care measures such as probiotics to help restore normal intestinal bacteria, dietary modifications to ease digestion, or in some cases, may switch to an alternative antibiotic that is better tolerated. It is important not to discontinue the antibiotic without veterinary guidance, as this could lead to treatment failure.

Hypersensitivity reactions to cefalexin are possible, though relatively uncommon in dogs. Signs of an allergic reaction may include hives, facial swelling, intense itching or scratching, difficulty breathing, or in severe cases, anaphylactic shock. Dogs with known allergies to other cephalosporin antibiotics or to penicillin-class antibiotics may have an increased risk of reacting to cefalexin. Any signs suggestive of an allergic reaction should be treated as an emergency requiring immediate veterinary care. Owners should always disclose any history of medication reactions before starting cefalexin therapy.

Rare side effects of cefalexin may include drooling, excessive salivation, or changes in behavior during treatment. With prolonged use, some dogs may develop yeast infections of the skin or ears due to disruption of normal bacterial populations that normally keep yeast in check. Effects on blood cell production are possible but rare at standard therapeutic doses. Any unusual symptoms that develop during cefalexin therapy should prompt a call to the veterinarian to determine whether the medication should be continued or an alternative approach is warranted.

Cefalexin should not be administered to dogs with a documented hypersensitivity or allergy to cephalosporin antibiotics. Dogs that have experienced allergic reactions to cefalexin itself or to other members of the cephalosporin class, including cefadroxil, cefovecin, or cefpodoxime, should not receive this medication. Allergic reactions can range from mild skin reactions to severe anaphylaxis, which can be life-threatening if not treated immediately. A complete medical history including any previous adverse reactions to medications should be discussed with the veterinarian before initiating antibiotic therapy.

Dogs with known allergies to penicillin-class antibiotics require careful evaluation before receiving cefalexin. Cross-reactivity between penicillins and cephalosporins exists due to the shared beta-lactam ring structure of these antibiotic classes. While the actual rate of cross-reactivity is lower than historically estimated, veterinarians typically exercise caution when considering cephalosporins for dogs with a history of penicillin allergy. The nature and severity of the previous reaction influences this decision, with severe allergic reactions representing a stronger contraindication than mild adverse effects.

Significant kidney impairment may require dose adjustment or alternative antibiotic selection rather than standard cefalexin therapy. Because cefalexin is primarily eliminated through the kidneys, dogs with compromised renal function may not clear the drug normally, leading to accumulation and increased risk of adverse effects. The veterinarian will assess kidney function through blood work and urine testing before prescribing cefalexin to dogs with known or suspected kidney disease. In cases of moderate to severe renal impairment, the veterinarian may choose an antibiotic with a different elimination pathway or adjust the dosing interval.

Pregnancy and lactation status should be communicated to the veterinarian, as the safety of cefalexin in pregnant and nursing dogs has not been definitively established through controlled studies. Cephalosporins are generally considered among the safer antibiotic classes during pregnancy in many species, but the decision to use cefalexin in a pregnant dog must consider the severity of the infection and the potential risks of leaving it untreated versus any theoretical risks of medication. Nursing dogs may pass small amounts of cefalexin to puppies through milk. The veterinarian will determine the most appropriate course of action based on the individual clinical situation.

Complete disclosure of all medications, supplements, and treatments the dog is receiving is essential before starting cefalexin therapy. Drug interactions can significantly affect how cefalexin works in the body, potentially reducing its effectiveness or increasing the risk of adverse effects. This includes prescription medications, over-the-counter products, herbal remedies, and nutritional supplements. The veterinarian needs this complete picture to make informed decisions about antibiotic selection and to anticipate potential problems.

Cefalexin may interact with other medications that affect kidney function or compete for similar elimination pathways. Aminoglycoside antibiotics, such as gentamicin, when used concurrently with cephalosporins may increase the risk of kidney damage, particularly in patients with pre-existing renal compromise. Certain nonsteroidal anti-inflammatory drugs can also affect kidney function and may interact with cefalexin. Probenecid, a medication that affects renal tubular secretion, can increase blood levels of cephalosporins by decreasing their elimination, which may require dose adjustment. The veterinarian will carefully evaluate all concurrent medications for potential interactions.

Antacids, sucralfate, and other medications that alter gastrointestinal pH or bind to drugs in the digestive tract may affect the absorption of oral cefalexin. While this interaction is generally less significant for cefalexin than for some other antibiotics, optimal absorption may be achieved by separating administration of these products by two to three hours. If the dog is receiving medications for gastrointestinal conditions, the veterinarian can provide specific guidance on timing of various medications to minimize any potential interactions.

Probiotics and beneficial bacteria supplements are commonly given to dogs receiving antibiotics to help maintain healthy intestinal flora. While generally safe to use alongside cefalexin, administering probiotics at different times than the antibiotic may help protect the beneficial bacteria from the antibiotic's effects. Some veterinarians recommend giving probiotics midway between antibiotic doses. The use of any supplements should be discussed with the veterinarian to ensure they do not interfere with treatment effectiveness. Monitoring for signs of treatment success, such as resolution of infection symptoms, helps identify any issues that might suggest drug interactions or treatment failure.

General precautions for cefalexin use in dogs include ensuring accurate dosing based on current, measured body weight and strict adherence to the prescribed dosing schedule. The wide range of body sizes in dogs, from tiny toy breeds to massive giants, makes weight-based dosing essential for both safety and efficacy. Dogs should be weighed at the veterinary clinic using an accurate scale before starting antibiotic therapy, and owners should not rely on estimated weights. Taking the medication exactly as prescribed, at the recommended intervals, maximizes therapeutic effectiveness.

Breed-specific concerns with cefalexin are minimal compared to some other medication classes. Cefalexin does not fall within the categories of drugs most affected by the MDR1 gene mutation that occurs in many herding breeds. Unlike medications such as ivermectin, loperamide, or certain other drugs that can cause toxicity in MDR1-affected dogs, cefalexin can generally be used safely across all breeds without genetic testing requirements. However, individual dogs of any breed may have sensitivities or allergies to cephalosporin antibiotics, so monitoring during treatment remains important regardless of breed.

Environmental precautions include proper handling and storage of cefalexin to maintain medication integrity and prevent accidental ingestion by other household members. The medication should be kept in its original container with child-resistant caps properly secured. In homes with multiple pets, the treated dog should be monitored during medication administration to ensure complete dose consumption and prevent other animals from accessing the medication. Other pets should not receive cefalexin unless specifically prescribed by a veterinarian for their own diagnosed infections.

Monitoring during treatment involves observing the dog for both therapeutic response and potential adverse effects. Signs of improvement include resolution of clinical symptoms such as reduced redness, swelling, discharge, or discomfort at infection sites. Skin infections should show progressive improvement with healing of lesions and regrowth of hair. Failure to improve within several days of starting therapy, or worsening of symptoms, warrants veterinary reevaluation. The veterinarian may recommend follow-up examinations, repeat cultures, or blood work to assess treatment response.

Special populations requiring additional consideration include geriatric dogs, puppies, and dogs with chronic health conditions. Senior dogs may have reduced kidney function that affects drug elimination, potentially requiring modified dosing or more careful monitoring. Young puppies have developing organs that metabolize medications differently than adult dogs. Dogs with diabetes, immunosuppressive conditions, liver disease, or other chronic medical problems may need modified treatment approaches. The veterinarian considers all of these factors when designing an appropriate cefalexin treatment protocol for each individual patient.

Cefalexin capsules and tablets should be stored at controlled room temperature, typically between 59°F and 86°F (15°C to 30°C), in a dry location protected from direct sunlight and excessive heat. The original container provides optimal protection from light and moisture, so medication should remain in its original packaging until administration. Avoiding storage in bathrooms, kitchens, or other areas with high humidity or temperature fluctuations helps maintain medication potency throughout the treatment course. The expiration date on the packaging should be checked before use, as expired antibiotics may have reduced effectiveness.

Oral suspension formulations of cefalexin have specific storage requirements that may differ from tablets and capsules. Once reconstituted from powder form, the suspension typically requires refrigeration to maintain stability, though specific instructions vary by product. The suspension should be shaken vigorously before each use to ensure uniform distribution of the medication. Reconstituted suspensions have a limited shelf life, usually one to two weeks after mixing, regardless of the original expiration date. Any remaining suspension after completing treatment or after the beyond-use date should be properly disposed of rather than saved for potential future use.

Safe handling and disposal of cefalexin protects both household members and the environment. All medications should be stored securely out of reach of children and pets. While cefalexin is not typically highly palatable to dogs, all medications should be treated as potential hazards if consumed in uncontrolled amounts. Unused or expired cefalexin should be disposed of properly through veterinary clinic take-back programs, pharmacy disposal options, or following current guidelines for safe home medication disposal. Antibiotics should not be flushed down drains or toilets due to environmental concerns related to antimicrobial resistance in water supplies.

Cefalexin can be used safely in dogs of all breeds without specific genetic precautions that would limit its use. Unlike certain drug classes that require caution in breeds carrying the MDR1 gene mutation, cephalosporin antibiotics like cefalexin are not substrates for the P-glycoprotein transporter affected by this mutation. This means that Collies, Australian Shepherds, Shetland Sheepdogs, Border Collies, and other breeds commonly affected by MDR1 mutations can receive cefalexin at standard doses without increased risk of drug accumulation or toxicity related to their genetic status.

Size considerations are important when selecting formulations and doses of cefalexin for dogs of different breeds. Toy and small breeds such as Chihuahuas, Pomeranians, Yorkshire Terriers, and Maltese often require the use of oral suspension or carefully divided tablets to achieve accurate dosing. The margin for error is smaller in tiny dogs, where even minor dose variations represent a significant percentage of the intended amount. Giant breeds including Great Danes, Irish Wolfhounds, Mastiffs, and Saint Bernards require proportionally larger doses that may necessitate administration of multiple capsules or tablets at each dosing time.

Certain breed predispositions to conditions commonly treated with cefalexin may mean that some breeds encounter this medication more frequently than others. Brachycephalic breeds with facial skin folds, including Bulldogs, Pugs, and Boston Terriers, are prone to fold dermatitis and secondary bacterial infections. Breeds predisposed to allergic skin disease, such as French Bulldogs, Labrador Retrievers, Golden Retrievers, and West Highland White Terriers, may experience recurrent skin infections requiring periodic antibiotic therapy. While these breed predispositions do not change how cefalexin works, they do influence the likelihood of prescription.

Age considerations apply across all breeds and become particularly relevant at the extremes of the lifespan. Puppies have immature liver and kidney function that affects drug metabolism and elimination, potentially requiring adjusted dosing or closer monitoring during treatment. Senior dogs, especially large and giant breeds that age more rapidly, may have declining organ function that influences how cefalexin is handled by the body. The veterinarian evaluates each patient individually, considering both breed and age factors when designing appropriate treatment protocols.

Cefalexin belongs to the first-generation cephalosporin class alongside other antibiotics with similar mechanisms of action and spectrums of activity. Cefadroxil (Cefa-Tabs) is a closely related first-generation cephalosporin commonly prescribed for dogs, offering the potential advantage of once or twice daily dosing compared to the two to three times daily administration often required for cefalexin. Cefazolin is a first-generation cephalosporin available only in injectable form, frequently used in veterinary hospitals for surgical prophylaxis and treatment of serious infections. These first-generation agents share effectiveness against common gram-positive bacteria and select gram-negative organisms.

Advanced-generation cephalosporins are available when broader spectrum coverage or specific characteristics are needed. Cefpodoxime (Simplicef) is a third-generation oral cephalosporin with enhanced activity against gram-negative bacteria compared to first-generation agents, making it useful for certain infections not susceptible to cefalexin. Cefovecin (Convenia) is a unique long-acting injectable cephalosporin that provides antibiotic activity for approximately two weeks following a single injection, offering an alternative for dogs that are difficult to medicate orally. These newer-generation cephalosporins may be reserved for specific clinical situations as part of responsible antibiotic stewardship practices.

Alternative antibiotic classes may be considered when cephalosporins are not appropriate or effective for a particular infection. Amoxicillin and amoxicillin-clavulanate (Clavamox) are penicillin-class antibiotics with overlapping but not identical spectrums of activity. Fluoroquinolones such as enrofloxacin provide broad-spectrum coverage but are often held in reserve due to concerns about resistance development. Clindamycin offers good activity against anaerobic bacteria and some gram-positive organisms. Culture and sensitivity testing helps guide antibiotic selection when infections fail to respond to initial therapy. Veterinary guidance is essential for selecting alternative antibiotics, as improper substitution can lead to treatment failure and contribute to antimicrobial resistance.